Typically, immune cells secrete IFNγ to exert anti‐tumor functions; CD8+ cytotoxic T lymphocytes are key producers of IFNγ and critical cells in the anti‐tumor immune process.[33, 43] IFNγ may play a crucial role in immune therapy response. This evidence concerns the gene CD8A and neoplasm.